Company / PP&E (Net)
IQVIA PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$533.0M
FY2025
5-year range
$497.0M / $535.0M
FY2021-FY2025
Trend
-0.4%
vs FY2024
Sector context
#51 of 132
Health Care
What the data says
At $533M, IQVIA's pp&e (net) ranks #51 of 132 in the Health Care sector. PP&E (Net) has fluctuated over the past 10 years, ranging from $406M in FY2016 to $535M in FY2024.
Based on SEC 10-K filings.
$533M in FY2025 with a 5-year CAGR of +2.0%.
Remained stable around $533M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +0.1%
- 5-Year CAGR
- +2.0%
- 10-Year CAGR
- -
Sector benchmark
#51 of 132 in Health CareTop 39% of 132This company $533.0M Sector average $1.4B
▼
-62.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +2.0%, indicating consistent growth.
- In FY2025, pp&e (net) decreased 0.4% year-over-year.
- Ranks #51 out of 132 companies in the Health Care sector.
- Peak pp&e (net) was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 20.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $533.0M | -0.4% |
| FY2024 | $535.0M | +2.3% |
| FY2023 | $523.0M | -1.7% |
| FY2022 | $532.0M | +7.0% |
| FY2021 | $497.0M | +3.1% |
| FY2020 | $482.0M | +5.2% |
| FY2019 | $458.0M | +5.5% |
| FY2018 | $434.0M | -1.4% |
| FY2017 | $440.0M | +8.4% |
| FY2016 | $406.0M | +116.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026